Celebrex Capsule 200 mg (Celecoxib)

Adult dose

The minimum recommended dose of this medicine should be adjusted according to the patient and may be administered with or without food. Osteoarthritis (degenerative arthritis) Take 200 mg of celecoxib once daily, or 100 mg per dose in 2 divided doses daily. Rheumatoid arthritis Take 100 mg or 200 mg of celecoxib per dose twice daily. Ankylosing spondylitis (AS) Administer 200 mg of celecoxib once daily, or 100 mg per dose in 2 divided doses daily. If no effect is observed after 6 weeks, the dose may be increased to 400 mg daily. If no effect is observed after 6 weeks of treatment with 400 mg daily, another treatment method should be considered. Acute pain and primary dysmenorrhea The recommended initial dose is 400 mg of celecoxib, with an additional 200 mg on the first day of treatment if necessary. From the second day of treatment, the recommended dose, if needed, is 200 mg per dose twice daily. Patients with hepatic impairment In patients with moderate hepatic impairment (Child-Pugh Class II), the dose should be reduced to approximately 50% of the recommended daily dose.

Individuals who consume large amounts of alcohol daily should consult with a doctor or pharmacist before taking this medication. Taking it with alcohol may increase the risk of gastrointestinal bleeding. This medication may increase the risk of problems with the heart or cerebral blood vessels; therefore, it should be used at the lowest effective dose for the shortest period necessary. Symptoms should be closely monitored, and if chest pain or shortness of breath occurs, immediate medical attention is required. It can also affect the gastrointestinal system and may lead to serious issues such as ulcers, bleeding, or perforation. Those who are elderly or have a history of gastrointestinal disorders should be especially cautious, and if symptoms such as abdominal pain, indigestion, black stools, or vomiting blood occur, they should visit a hospital immediately. Patients allergic to this medication or with certain diseases, pregnant or breastfeeding women, and individuals with severely impaired heart or kidney function should not take this medication. Those with compromised liver or kidney function, asthma, heart failure, hypertension, or diabetes should use this medication with caution and regularly consult a doctor while taking it. Dizziness or drowsiness may occur while taking this medication, so it is advisable to avoid driving or operating machinery. This medication may interact with other drugs; therefore, anyone taking other medications should inform their doctor or pharmacist. Women planning to become pregnant should be cautious, as this medication may affect fertility. If taking this medication for an extended period, regular blood tests and liver and kidney function tests should be conducted, and if abnormal symptoms arise, immediate medical consultation is necessary. Safety and efficacy for children and adolescents have not been established, so it is best not to use it for this population. This medication should be stored out of reach of children and not transferred to another container for safety.

Gastrointestinal bleeding, cardiovascular thrombosis, myocardial infarction, stroke, upper and lower gastrointestinal perforation, ulcer, bleeding, bronchitis, sinusitis, upper respiratory tract infection, urinary tract infection, pharyngitis, rhinitis, anemia, thrombocytopenia, hypersensitivity, insomnia, anxiety, confusional state, dizziness, muscle tension, drowsiness, blurred vision, tinnitus, palpitations, congestive heart failure, arrhythmia, tachycardia, hypertension, flushing, cough, vomiting, abdominal pain, diarrhea, dyspepsia, bloating, gastric ulcer, dental disease, duodenal ulcer, esophageal ulcer, intestinal perforation, pancreatitis, elevated liver enzymes, itching, rash, urticaria, angioedema, alopecia, blistering dermatitis, peripheral edema, facial edema, influenza-like illness, injury, taste disturbance, albuminuria, cystitis, hematuria, dysuria, polyuria, nephrolithiasis, urinary incontinence, urinary tract infection, visual disturbance, cataracts, conjunctivitis, eye pain, glaucoma, ocular hemorrhage, retinal artery or vein occlusion, increased serum creatinine, increased β2-microglobulin, increased NAG, hematuria positive, proteinuria positive, kidney dysfunction, acute kidney injury, interstitial nephritis, increased serum sodium, increased serum potassium, elevated BUN, increased CPK, diabetes mellitus, hypercholesterolemia, hyperglycemia, hypokalemia, hyperkalemia, increased NPN, increased creatinine, increased alkaline phosphatase, weight gain, anorexia, increased LDH, hypoglycemia, hyponatremia, bursitis, arthralgia, arthritis, skeletal abnormalities, myalgia, cervical dystonia, synovitis, tendinitis, myositis, leg cramps, fractures, tendon rupture, pain in various areas, muscle stiffness, decreased hematocrit, increased hemoglobin, petechiae, epistaxis, thrombocytopathy, agranulocytosis, aplastic anemia, pancytopenia, leukopenia, granulomatous inflammation, contact dermatitis, injection site reaction, skin nodules, headache, leg cramps, sensation reduction, migraine, neuralgia, neuropathy, sensory abnormality, cerebral infarction, aseptic meningitis, ataxia, suicide, loss of smell, loss of taste, exacerbation of allergies, allergic reaction, weakness, chest pain, fluid retention, systemic edema, facial edema, fatigue, malaise, fever, facial flushing, influenza-like syndrome, pain, peripheral pain, septicemia, sudden death, anaphylactic-like reaction, vasculitis, pulmonary embolism, interstitial pneumonia, hepatitis, liver failure, fulminant hepatitis, liver necrosis, cholestasis, cholestatic hepatitis, jaundice, photosensitivity reaction, Stevens-Johnson syndrome, erythema multiforme, toxic epidermal necrolysis, drug rash, acute generalized exanthematous pustulosis, exfoliative dermatitis, generalized fixed drug eruption, fixed drug eruption, menstrual disorders, female infertility, hallucinations, epistaxis, voice disorder, dyspnea, hearing loss, ear abnormalities, otalgia, hearing impairment, cholelithiasis, hepatitis, jaundice, liver failure, fulminant hepatitis, liver necrosis, acute kidney injury, hyponatremia, tubulointerstitial nephritis, nephrotic syndrome, minimal change disease glomerulonephritis

Store this medication in a tightly sealed container to prevent exposure to air, and the appropriate storage temperature is between 15°C and 30°C. Proper storage will help maintain the effectiveness of the medication.

Appearance

A hard capsule with a white to light yellow powder filled inside, with a white upper and lower part.

Package unit

30 capsules/bottle, 100 capsules/bottle